These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 30814239)

  • 1. Title Prognosis Significance of ZEB2 and TGF-β1 as well as Other Clinical Characteristics in Epithelial Ovarian Cancer.
    Yan Z; Tian X; Wang R; Cheng X; Mi J; Xiong L; Wang Y; Deng J; Jia M
    Int J Gynecol Cancer; 2017 Sep; 27(7):1343-1349. PubMed ID: 30814239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Significance of Zinc Finger E-Box-Binding Homeobox Family in Glioblastoma.
    Chen P; Liu H; Hou A; Sun X; Li B; Niu J; Hu L
    Med Sci Monit; 2018 Feb; 24():1145-1151. PubMed ID: 29476046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expressions of ZEB2 and C-myc in epithelial ovarian cancer and their clinical significance].
    Wang Q; Jiang H; Deng X; Fang W; Guo S
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 Dec; 35(12):1765-9. PubMed ID: 26714913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Significance of Increased Expression of Annexin A10 (ANXA10) in Serous Epithelial Ovarian Cancer.
    Wang J; Zhao S; Wang F; Wang J; Zhang Y
    Med Sci Monit; 2019 Jul; 25():5666-5673. PubMed ID: 31363077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ZEB2 facilitates peritoneal metastasis by regulating the invasiveness and tumorigenesis of cancer stem-like cells in high-grade serous ovarian cancers.
    Li Y; Fei H; Lin Q; Liang F; You Y; Li M; Wu M; Qu Y; Li P; Yuan Y; Chen T; Jiang H
    Oncogene; 2021 Aug; 40(32):5131-5141. PubMed ID: 34211089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined score of pretreatment platelet count and CA125 level (PLT-CA125) stratified prognosis in patients with FIGO stage IV epithelial ovarian cancer.
    Chen JP; Huang QD; Wan T; Tu H; Gu HF; Cao JY; Liu JH
    J Ovarian Res; 2019 Jul; 12(1):72. PubMed ID: 31362750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical associations between ASCT2 and p‑mTOR in the pathogenesis and prognosis of epithelial ovarian cancer.
    Guo H; Xu Y; Wang F; Shen Z; Tuo X; Qian H; Wang H; Wang K
    Oncol Rep; 2018 Dec; 40(6):3725-3733. PubMed ID: 30272366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of TRIM24 predicts worse prognosis and promotes proliferation and metastasis of epithelial ovarian cancer.
    Zhang L; Chen H; Ding B; Jiang W
    J Ovarian Res; 2022 Feb; 15(1):19. PubMed ID: 35105347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of GPNMB predicts an unfavorable outcome of epithelial ovarian cancer.
    Ma RQ; Tang ZJ; Ye X; Cheng HY; Sun KK; Chang XH; Cui H
    Arch Gynecol Obstet; 2018 May; 297(5):1235-1244. PubMed ID: 29428978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
    Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
    J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor expression correlates with serum CA125 and represents a useful tool in prediction of refractoriness to platinum-based chemotherapy and ascites formation in epithelial ovarian cancer.
    Masoumi-Moghaddam S; Amini A; Wei AQ; Robertson G; Morris DL
    Oncotarget; 2015 Sep; 6(29):28491-501. PubMed ID: 26143638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression of ubiquitin-conjugating enzyme E2C and KAI1 in ovarian carcinoma and their clinical significance.
    Gong Y; Wang D; Lin L; Dai J; Yu L
    Medicine (Baltimore); 2019 Nov; 98(46):e17896. PubMed ID: 31725636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The relationship of preoperativelymphocyte-monocyte ratio and the clinicopathological characteristics and prognosis of patients with epithelial ovarian cancer].
    Yang HM; Lou G
    Zhonghua Zhong Liu Za Zhi; 2017 Sep; 39(9):676-680. PubMed ID: 28926896
    [No Abstract]   [Full Text] [Related]  

  • 14. Multivariate analysis by Cox proportional hazard model on prognosis of patient with epithelial ovarian cancer.
    Wang M; He Y; Shi L; Shi C
    Eur J Gynaecol Oncol; 2011; 32(2):171-7. PubMed ID: 21614907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ZEB2 promotes vasculogenic mimicry by TGF-β1 induced epithelial-to-mesenchymal transition in hepatocellular carcinoma.
    Yang Z; Sun B; Li Y; Zhao X; Zhao X; Gu Q; An J; Dong X; Liu F; Wang Y
    Exp Mol Pathol; 2015 Jun; 98(3):352-9. PubMed ID: 25818166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of centrosomal protein 55 is associated with unfavorable prognosis and tumor invasion in epithelial ovarian carcinoma.
    Zhang W; Niu C; He W; Hou T; Sun X; Xu L; Zhang Y
    Tumour Biol; 2016 May; 37(5):6239-54. PubMed ID: 26615423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of serum transforming growth factor-beta 1 (TGF-β1) levels in patients with epithelial ovarian cancer.
    Tas F; Karabulut S; Serilmez M; Ciftci R; Duranyildiz D
    Tumour Biol; 2014 Apr; 35(4):3611-6. PubMed ID: 24310505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of Siah2 Is Associated With Poor Prognosis in Patients With Epithelial Ovarian Carcinoma.
    Gao Y; Liu Y; Meng F; Shang P; Wang S; Zhang Y; Sun Y; Wang Y; Wang J; Chen X
    Int J Gynecol Cancer; 2016 Jan; 26(1):114-9. PubMed ID: 26512788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between plasma PSGL-1 and FIGO stage, tumor metastasis, and survival in epithelial ovarian cancer.
    Li W; Fang C; Gao Y; Gao Y; Yan F; Chen B; Xu M
    Biotechnol Appl Biochem; 2024 Aug; 71(4):733-740. PubMed ID: 38494670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CDKN3 is an independent prognostic factor and promotes ovarian carcinoma cell proliferation in ovarian cancer.
    Li T; Xue H; Guo Y; Guo K
    Oncol Rep; 2014 Apr; 31(4):1825-31. PubMed ID: 24573179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.